California Medicaid providers win legal challenge

NewsGuard 100/100 Score

Medicaid providers in California won a legal challenge over program cuts in the case "Maxwell-Jolly v. Independent Living Center of Southern California."

McKnight's Long Term Care News reports that "The U.S. Supreme Court has let stand a federal appeals court ruling that says California's Medicaid providers have a right to challenge state cuts to Medi-Cal provider fees. Victor Norma Jean Vescovo, the executive director of the Independent Living Center of Southern California, says the ruling will make it easier to ensure state Medicaid (known in the state as Medi-Cal) cuts will be made for needs-based reasons, not just economic reasons, the Bureau of National Affairs reported.

"The Supreme Court's decision to deny a review could set a precedent for providers across the country to challenge state cuts to Medicaid fees and services under the Medicaid Act. California currently is facing a major budget deficit of $24 billion for the fiscal year beginning July 1. Gov. Arnold Schwarzenegger (R) has proposed a series of drastic cuts to state services, including the state's Medicaid program, which funds a major portion of nursing home costs" (6/24).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment